4Article 3 of Regulation No 297/95, entitled ‘Medicinal products for human use covered by the procedures laid down in Regulation (EC) No 726/2004’, provided as follows:1. Authorisation to market a medicinal product…2. Variation to a marketing authorisation(a) Type 1 variation feeA type I variation fee shall apply for a minor variation to a marketing authorisation, as defined in Article 3(2) of [Commission Regulation (EC) No 1085/2003 of 3 June 2003 concerning the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products falling within the scope of Council Regulation (EEC) No 2309/93 (OJ 2003 L 159, p. 24)]. For type IA variations, the fee shall be EUR 2900. For type IB variations, the fee shall be EUR 6700.In the event of the same variation being introduced, this fee shall cover all authorised strengths, pharmaceutical forms and presentations.…’
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.